These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3937295)

  • 1. GHRF test in acromegalic patients for the evaluation of therapeutic results.
    Hanew K; Sato S; Sasaki A; Goh M; Shimizu Y; Murakami O; Yoshinaga K
    Tohoku J Exp Med; 1985 Nov; 147(3):273-80. PubMed ID: 3937295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study on the responses of plasma GH to synthetic GH-releasing factor and other stimulatory and inhibitory agents in patients with acromegaly.
    Hanew K; Sato S; Sasaki A; Shimizu Y; Murakami O; Yoshinaga K
    Tohoku J Exp Med; 1985 Feb; 145(2):161-6. PubMed ID: 2859672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary hormone responses to hypothalamic releasing hormones in acromegaly.
    Cantalamessa L; Reschini E; Catania A; Giustina G
    Acta Endocrinol (Copenh); 1976 Dec; 83(4):673-83. PubMed ID: 826061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal growth hormone responses to L-dopa and thyrotropin-releasing hormone in patients with acromegaly.
    Hanew K; Aida M; Tano T; Yoshinaga K
    Tohoku J Exp Med; 1977 Mar; 121(3):197-206. PubMed ID: 404727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.
    Thorner MO; Perryman RL; Cronin MJ; Rogol AD; Draznin M; Johanson A; Vale W; Horvath E; Kovacs K
    J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].
    De Marinis L; Mancini A; Zuppi P; Fiumara C; Iacona T; Conte G; Fabrizi ML; Valle D; Anile C; Maira G
    Minerva Chir; 1993 Nov; 48(21-22):1337-40. PubMed ID: 8152567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium signalling in single growth hormone-releasing factor-responsive pituitary cells.
    Cuttler L; Glaum SR; Collins BA; Miller RJ
    Endocrinology; 1992 Feb; 130(2):945-53. PubMed ID: 1733736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretion of growth hormone-releasing hormone in patients with idiopathic pituitary dwarfism and acromegaly.
    Yamasaki R; Saito H; Kameyama K; Hosoi E; Saito S
    Acta Endocrinol (Copenh); 1988 Mar; 117(3):273-81. PubMed ID: 2898191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
    J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of corticotrophin-releasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies.
    Colao A; Merola B; Ferone D; Calabrese MR; Longobardi S; Spaziante R; Di Renzo G; Annunziato L; Lombardi G
    Eur J Endocrinol; 1994 Jul; 131(1):14-9. PubMed ID: 8038903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
    Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison with growth hormone responses to various drugs or substances in patients with active acromegaly (author's transl)].
    Takahara J; Ogawa N; Hosogi H; Aoki Y; Yamauchi J
    Nihon Naibunpi Gakkai Zasshi; 1975 Oct; 51(10):803-12. PubMed ID: 821792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma growth hormone responses to sulpiride in patients with acromegaly.
    Hanew K; Sato S; Sasaki A; Kasai M; Shimizu Y; Murakami O; Yoshinaga K
    Tohoku J Exp Med; 1984 Apr; 142(4):445-52. PubMed ID: 6429896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotropin releasing hormone (TRH)-induced release of 7B2 (neuroendocrine polypeptide) in vivo and in vitro using adenoma cells of a patient with acromegaly.
    Natori S; Iguchi H; Ohashi M; Kitamoto T; Chrétien M; Nawata H
    Jpn J Med; 1991; 30(3):208-12. PubMed ID: 1920959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normalization of thyroid stimulating hormone levels in acromegalic patients after selective adenomectomy.
    Tsuchiya H; Onishi T; Mori S; Lee S; Kohno H; Imanaka S; Saitoh Y; Mogami H; Uozumi T; Kumahara Y
    Endocrinol Jpn; 1984 Dec; 31(6):687-95. PubMed ID: 6442697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the results of trans-sphenoidal surgery in acromegaly by assessment of the growth hormone response to thyrotrophin-releasing hormone.
    Faglia G; Paracchi A; Ferrari C; Beck-Peccoz P
    Clin Endocrinol (Oxf); 1978 May; 8(5):373-80. PubMed ID: 417883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human pancreatic growth hormone-releasing factor (hpGRF-44) in acromegaly before and after adenomectomy. Modifications induced by somatostatin (GHRIH) infusion.
    Arosio M; Ambrosi B; Guglielmino L; Faglia G
    J Endocrinol Invest; 1985 Oct; 8(5):449-53. PubMed ID: 2867112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of pre- and postsurgical evaluation of abnormal GH responses in acromegaly.
    Arosio M; Giovanelli MA; Riva E; Nava C; Ambrosi B; Faglia G
    J Neurosurg; 1983 Sep; 59(3):402-8. PubMed ID: 6411870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy.
    Giusti M; Lomeo A; Monachesi M; Mazzocchi G; Attanasio R; Sessarego P; Mignone D; Del Monte P; Giordano G
    J Endocrinol Invest; 1987 Apr; 10(2):143-51. PubMed ID: 3108356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal growth hormone responses to CB-154 and thyrotropin-releasing hormone (TRH) in patients with acromegaly.
    Hanew K; Aida M; Sasaki A; Mouri T; Yoshinaga K
    Tohoku J Exp Med; 1979 Jan; 127(1):53-62. PubMed ID: 104407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.